Why Myriad Genetics Inc. Shares Were Clobbered – Motley Fool

See on Scoop.itBioTechnology

Why Myriad Genetics Inc. Shares Were Clobbered Motley Fool What: Shares of Myriad Genetics (NASDAQ: MYGN ) , a molecular diagnostics company best known for its BRACAnalysis BRCA 1 & 2 gene test, slumped as much as 17% after the Centers for Medicare…

See on www.fool.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: